This may be possibly due to decreased expression of cyclin D1, cyclin-dependent kinase 4 (CDK4) and CDK6 and increased expression of p27, indicating that CMTM7 acts as a tumor suppressor by inhibiting cell cycle progression in HCC. This evidence concerns the gene CDK4 and hepatocellular carcinoma.